Lumos Pharma Inc. (LUMO)
NASDAQ: LUMO
· Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM
Lumos Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -7.47M | -7.55M | -10.44M | -9.46M | -8.3M | -8.93M | -7.35M | -8.25M | -7.25M | -7.84M | -7.72M | -5.64M | -7.49M | -8.67M | -8.63M |
Depreciation & Amortization | -1K | 2K | 2K | 18K | 8K | 9K | 9K | 35K | 4K | -2K | 12K | 9K | 8K | 16K | 170K |
Stock-Based Compensation | 379K | 387K | 580K | 524K | 559K | 653K | 586K | 587K | 593K | 575K | 565K | 494K | 490K | 846K | 1.05M |
Other Working Capital | 550K | 260K | -437K | -1.5M | 320K | 169K | 1.69M | -138K | 472K | 293K | -1.01M | 674K | -50K | 1.43M | -1.58M |
Other Non-Cash Items | -169K | -131K | 3.18M | -189K | -91K | -135K | -136K | -26K | 679K | 984K | 477K | -24.07M | 1K | 13K | 2.74M |
Deferred Income Tax | n/a | n/a | n/a | 159K | n/a | n/a | n/a | n/a | n/a | -984K | n/a | 24.07M | n/a | n/a | n/a |
Change in Working Capital | 2.25M | 782K | -3.03M | 1.55M | 4K | 1.72M | -2.31M | 1.82M | 1.14M | 26K | -890K | -690K | -50K | 1.43M | -3M |
Operating Cash Flow | -5.01M | -6.38M | -12.89M | -7.39M | -7.82M | -6.68M | -9.2M | -5.83M | -5.52M | -7.25M | -8.03M | -5.83M | -7.04M | -6.37M | -10.41M |
Capital Expenditures | n/a | n/a | n/a | -13.21M | 6.38M | -3.92M | -2.46M | -21K | n/a | n/a | n/a | -13K | -7K | -10K | n/a |
Cash Acquisitions | n/a | n/a | n/a | 7.03M | -5.95M | -1.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -998K | -6.38M | -3.92M | -2.46M | -11.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | 1M | 7.17M | 5.95M | 5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1M | n/a | 1M | 6.17M | 5.95M | 3.92M | 2.46M | -11.34M | n/a | n/a | n/a | -20K | n/a | -10K | 26M |
Investing Cash Flow | n/a | n/a | 1M | 6.17M | 5.95M | 1.08M | -2.46M | -11.36M | n/a | n/a | n/a | -13K | -7K | -10K | 26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 16K | -11K | -5K | n/a | -426K | -579K | -305K | -478K | -197K | -32K | -5K | n/a | n/a | -70K | -44K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4K | -11K | -5K | 17K | -9K | 5K | -4K | 3K | -129K | -2K | -18K | n/a | n/a | -26K | -166K |
Financial Cash Flow | 1.73M | n/a | -5K | 742K | -435K | -574K | -309K | -475K | -326K | -2K | -18K | n/a | n/a | -26K | -166K |
Net Cash Flow | -3.28M | -6.38M | -11.9M | -479K | -2.31M | -6.18M | -11.97M | -17.66M | -5.84M | -7.25M | -8.05M | -5.84M | -7.05M | -6.41M | 15.42M |
Free Cash Flow | -5.01M | -6.38M | -12.89M | -20.6M | -1.44M | -10.6M | -11.66M | -5.85M | -5.52M | -7.25M | -8.03M | -5.84M | -7.05M | -6.38M | -10.41M |